Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome

Figure 1

H&E and IHC staining of CYP39A1 proteins in representative tissue of HCC mice. (a) Wild-type mice, H&E staining; (b) HCC mice, H&E staining; (c) wild-type mice, IHC staining of CYP39A1; (d) HCC mice, IHC staining of CYP39A1; (e) the junction of hepatocellular carcinoma and paracancerous liver tissue in the same field of HCC mice, IHC staining of CYP39A1; (f) negative control; original magnification, ×100.

(a)

(b)

(c)

(d)

(e)

(f)